BNP Paribas Financial Markets’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $41.5K | Sell |
|
|||||
|
2024
Q3 | $127K | Sell |
|
|||||
|
2024
Q2 | $296K | Sell |
|
|||||
|
2024
Q1 | $1.04M | Buy |
|
|||||
|
2023
Q4 | $421K | Sell |
|
|||||
|
2023
Q3 | $1.63M | Sell |
|
|||||
|
2023
Q2 | $5.61M | Sell |
|
|||||
|
2023
Q1 | $9.83M | Buy |
|
|||||
|
2022
Q4 | $4.11M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $231K | Buy |
|
|||||
|
2022
Q1 | $142K | Sell |
|
|||||
|
2021
Q4 | $261K | Sell |
|
|||||
|
2021
Q3 | $478K | Buy |
|
|||||
|
2021
Q2 | $259K | Sell |
|
|||||
|
2021
Q1 | $530K | Buy |
|
|||||
|
2020
Q4 | $345K | Sell |
|
|||||
|
2020
Q3 | $374K | Buy |
|
|||||
|
2020
Q2 | $57.5K | Sell |
|
|||||
|
2020
Q1 | $232K | Buy |
|
|||||
|
2019
Q4 | $85.4K | Sell |
|
|||||
|
2019
Q3 | $82.6K | Buy |
|
|||||
|
2019
Q2 | $55.4K | Sell |
|
|||||
|
2019
Q1 | $125K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $25.7K | Hold |
|
|||||
|
2018
Q2 | $28.4K | Sell |
|
|||||
|
2018
Q1 | $170K | Buy |
|
|||||
|
2017
Q4 | $173K | Buy |
|
|||||
|
2017
Q3 | $59.3K | Sell |
|
|||||
|
2017
Q2 | $60.7K | Buy |
|
|||||
|
2017
Q1 | $2.64K | Sell |
|
|||||
|
2016
Q4 | $23.7K | Sell |
|
|||||
|
2016
Q3 | $25.2K | Buy |
|
|||||
|
2016
Q2 | $13.3K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $134K | Buy |
|
|||||
|
2015
Q3 | $97.7K | Buy |
|
|||||
|
2015
Q2 | $41.6K | Buy |
|
|||||
|
2015
Q1 | $4.06K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $7.89K | Buy |
|